EP.12B.12 Intrinsic ALK-TKI Resistance Due to Met-Coamplification in ALK+ NSCLC, Effectively Treated by Alectinib-crizotinib Combination

E.m. Urbanska, L.c. Melchior, J.b. Sørensen, E. Santoni-rugiu

Research output: Contribution to journal › Journal article › Research › peer-review

Original language	English
Journal	Journal of Thoracic Oncology
Volume	19
Issue number	10
Pages (from-to)	S645-S646
Number of pages	2
ISSN	1556-0864
DOIs	https://doi.org/10.1016/j.jtho.2024.09.1217
Publication status	Published - 2024

Access to Document

@article{22866feeddbc46598cfae70837852d64,

title = "EP.12B.12 Intrinsic ALK-TKI Resistance Due to Met-Coamplification in ALK+ NSCLC, Effectively Treated by Alectinib-crizotinib Combination",

author = "E.m. Urbanska and L.c. Melchior and J.b. S{\o}rensen and E. Santoni-rugiu",

year = "2024",

doi = "10.1016/j.jtho.2024.09.1217",

language = "English",

volume = "19",

pages = "S645--S646",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier",

number = "10",

}

TY - JOUR

T1 - EP.12B.12 Intrinsic ALK-TKI Resistance Due to Met-Coamplification in ALK+ NSCLC, Effectively Treated by Alectinib-crizotinib Combination

AU - Urbanska, E.m.

AU - Melchior, L.c.

AU - Sørensen, J.b.

AU - Santoni-rugiu, E.

PY - 2024

Y1 - 2024

U2 - 10.1016/j.jtho.2024.09.1217

DO - 10.1016/j.jtho.2024.09.1217

M3 - Journal article

SN - 1556-0864

VL - 19

SP - S645-S646

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 10

ER -